Novavax COVID shot is approved by FDA advisers, raising possibility of a fourth U.S. vaccine option

This post was originally published on this site

https://content.fortune.com/wp-content/uploads/2022/06/GettyImages-1241112231.jpg



Novavax COVID shot is approved by FDA advisers, raising possibility of a fourth U.S. vaccine option | Fortune